Swedish expert calls for xenotranplantation reassessment:
This article was originally published in Clinica
Executive Summary
To successfully take xenotransplantation forward, researchers to concentrate on modifying pig genes rather than concentrating on developing a means to suppress the patient's immune system in order to avoid rejection, says a leading Swedish professor for transplantation surgery. Professor Carl-Gustav Groth of the Karolinska Institute told Lakartidningen that attempts to suppress the human immune system often had side-effects. He also said that pig cells should be considered alongside human cells in the field of cell transplantation, to treat diseases such as diabetes and Parkinson's.
You may also be interested in...
Drug Shortages, Inspections In Focus At US FDA Appropriations Hearing
Commissioner Robert Califf discussed the agency’s request for $12.3m to address shortages and legislation to require that manufacturers provide more detailed information about increased demand and supply chain vulnerabilities.
Parkinson’s Results Further Sweeten AbbVie’s Acquisition of Cerevel
Cerevel, which AbbVie is spending $8.7bn to acquire, unveiled topline results from the TEMPO-3 study of tavapadon, which an analyst said represents potentially a $1bn opportunity.
FDA’s New Dataset Aims To Assist Labs In Assessing Medical Device Biocompatibility
The US FDA’s device center has unveiled a new public dataset designed to assist chemistry laboratories in ensuring the robustness of chemical characterization methods used to assess the biocompatibility of medical devices.